BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10692029)

  • 1. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours.
    Chapel F; Fabiani B; Davi F; Raphael M; Tepper M; Champault G; Guettier C
    Histopathology; 2000 Mar; 36(3):252-61. PubMed ID: 10692029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma.
    Lee HS; Chang MS; Yang HK; Lee BL; Kim WH
    Clin Cancer Res; 2004 Mar; 10(5):1698-705. PubMed ID: 15014022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
    Moritani S; Sugihara H; Kushima R; Hattori T
    Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
    Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
    Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Fukuda T; Nakajima T; Nagamachi Y
    Jpn J Cancer Res; 1997 Mar; 88(3):262-6. PubMed ID: 9140110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
    Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.
    Gulley ML; Pulitzer DR; Eagan PA; Schneider BG
    Hum Pathol; 1996 Jan; 27(1):20-7. PubMed ID: 8543306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
    Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
    Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins.
    Ishii H; Gobé G; Kawakubo Y; Sato Y; Ebihara Y
    Histopathology; 2001 Feb; 38(2):111-9. PubMed ID: 11207824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
    Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
    Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) and gastric carcinoma in Malaysian patients.
    Karim N; Pallesen G
    Malays J Pathol; 2003 Jun; 25(1):45-7. PubMed ID: 16196377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clinicopathologic Parameters and Survivals Between Epstein-Barr Virus-positive and Her2-positive Gastric Cancers.
    Irkkan C; Balci S; Güler Tezel G; Akinci B; Yalcin B; Güler G
    Appl Immunohistochem Mol Morphol; 2017 Oct; 25(9):609-614. PubMed ID: 26945448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan.
    Harn HJ; Chang JY; Wang MW; Ho LI; Lee HS; Chiang JH; Lee WH
    Hum Pathol; 1995 Mar; 26(3):267-71. PubMed ID: 7890276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated gastric adenocarcinomas among Koreans.
    Shin WS; Kang MW; Kang JH; Choi MK; Ahn BM; Kim JK; Sun HS; Min KW
    Am J Clin Pathol; 1996 Feb; 105(2):174-81. PubMed ID: 8607441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus latent and replicative gene expression in gastric carcinoma.
    Selves J; Bibeau F; Brousset P; Meggetto F; Mazerolles C; Voigt JJ; Pradere B; Chiotasso P; Delsol G
    Histopathology; 1996 Feb; 28(2):121-7. PubMed ID: 8834519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma.
    Ott G; Kirchner T; Müller-Hermelink HK
    Histopathology; 1994 Oct; 25(4):323-9. PubMed ID: 7835837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
    World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features and protein expression study of Epstein-Barr virus-associated gastric carcinoma in Guangzhou].
    Han J; He D; Feng ZY; Ding YG; Shao CK
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):798-803. PubMed ID: 21215093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series.
    Kattoor J; Koriyama C; Akiba S; Itoh T; Ding S; Eizuru Y; Abraham EK; Chandralekha B; Amma NS; Nair MK
    J Med Virol; 2002 Nov; 68(3):384-9. PubMed ID: 12226826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma.
    Kume T; Oshima K; Shinohara T; Takeo H; Yamashita Y; Shirakusa T; Kikuchi M
    Histopathology; 1999 Jun; 34(6):502-9. PubMed ID: 10383694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.